Cargando…
LncRNA MIR31HG controls the proliferation and metastasis of gastric cancer by c-CBL-mediated degradation of β-catenin
Autores principales: | Peng, Wen, Zhang, Jiayi, Wang, Shenghao, Wang, Feng, Wang, Kun, Geng, Rui, Ding, Xiangfei, Zhang, Jingping, Li, Biao, Ke, Xiaoxue, Lü, Muhan, Cui, Hongjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308168/ https://www.ncbi.nlm.nih.gov/pubmed/37396518 http://dx.doi.org/10.1016/j.gendis.2022.12.022 |
Ejemplares similares
-
LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer
por: Xu, Yaqian, et al.
Publicado: (2021) -
MIR31HG, a potential lncRNA in human cancers and non-cancers
por: Ruan, Luxi, et al.
Publicado: (2023) -
Downregulated nuclear lncRNA NRON inhibits SHP2/Wnt/β-catenin signaling and cardiomyocyte differentiation during the development of Tetralogy of Fallot
por: Zhang, Hui, et al.
Publicado: (2022) -
Role of lncRNA MALAT1 in UVA-induced corneal endothelial senescence
por: Qiao, Yujie, et al.
Publicado: (2023) -
A lncRNA MEG3 variant enhances telomerase activity by increasing DNA damage repair ability in human liver cancer stem cells
por: Lu, Yanan, et al.
Publicado: (2022)